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Abstract
Takayasu arteritis (TA) is a large vessel vasculitis that usually affects young female patients during
the second and third decades of life, but has been reported in children as young as 24 months of
age. Aim of this report was to describe four children (two girls) with TA, as well as summarizing
main published studies. The mean age at presentation of our cases was 11 years (range 8–15).
Three patients were Caucasians and one Asian. Arterial hypertension was the commonest mode
of presentation followed by systemic symptoms. Other related symptoms were due to ischemia
and consisted of abdomen, chest, and limb pain. An abdominal bruit was noted in only one patient.
Inflammation markers were always abnormal. Angiography was performed in all cases; left
subclavian artery and common carotid artery were more frequently involved. Renal artery stenosis
was observed in two patients. One boy was diagnosed as having an associated immune deficiency
(Wiskott-Aldrich syndrome). Treatment modalities included prednisone (n = 4), methotrexate (n
= 3), and mycophenolate mofetil (MMF) (n = 1). Surgery was required in two patients. Follow-up
ranged from 3 to 10 years since diagnosis. In three cases antihypertensive drugs and methotrexate
were stopped, and prednisone was reduced to 7.5 mg/day.
Introduction
Takayasu arteritis (TA) is a large vessel vasculitis affecting
mainly the aorta and its major branches. TA occurs most
commonly in female patients in the second and third dec-
ades of life, but has also been reported in children as
young as 24 months of age [1]. The disease is more fre-
quent in Asian populations, but has been reported in
patients of all ethnical background. Descriptions of TA in
the pediatric age are scanty. Moreover, treatment options
have been limited so far, with few reports focusing on
immunosuppressive treatment (2 methotrexate, 1 cyclo-
phosphamide) in pediatric TA [2-4].
The aim of the present report was to describe four cases of
pediatric TA seen in a French tertiary pediatric rheumatol-
ogy center, with an emphasis on both medical and surgi-
cal management, as well as providing a recent review of
the literature. A representative clinical history is detailed
below, while Table 1 summarizes the characteristics of the
patients.
Case presentation
PH, male, with unremarkable family or past medical his-
tory, at the age of 11 years was admitted for the occurrence
of arterial hypertension (180/100 mm Hg) with the pres-
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His parents reported a history of fatigue, myalgia, frontal
headache and weight loss (9 kg) for the previous 2
months. On admission he was alert, afebrile and in no
acute distress. BP was 170/105 mm Hg. All his pulses were
felt and symmetric. Fundoscopy was normal. No abdom-
inal bruit was present. The rest of his physical examina-
tion was normal. Investigations on admission revealed
anemia (Hb 79 g/L), thrombocytosis (platelet count 738
G/L), ESR 125 mm/h, CRP 80 mg/L. The rest of laboratory
investigations, including serum creatinine, electrolytes,
autoantibodies, and urinalysis, were normal, as well as
ECG and chest X-ray. An echocardiogram showed mild
thickening of the left ventricle. A renal color Doppler
ultrasound examination revealed a right renal artery sten-
osis with a small ipsilateral kidney (70 mm vs 104 mm for
the left kidney). An angio-MRI demonstrated a thrombo-
sis in the left common carotid artery, a 70% stenosis of the
left subclavian artery, a 80% stenosis of the brachio-
cephalic artery, a thrombosis in the descending thoracic
aorta, and a right renal artery thrombosis and stenosis
(Figure 1). The boy was given prednisone 2 mg/kg per day,
antihypertensives (amlodipine 5 mg/day, enalapril 10
mg/day), as well as low-dose aspirin. After 2 weeks, ESR
fell to 26 mm/h and BP to 156/68 mm Hg. Surgery was
planned, but the patient relapsed at the prednisone dose
of 5 mg per day, so that daily dosage was increased up to
40 mg (1 mg/kg/d), and another immunosuppressive
(mycophenolate mofetil, MMF, 250 mg bid) was added.
Six months later he underwent revascularization bypass
surgery of brachiocephalic trunk (a femoral vein was used
as a graft between ascending aorta and right carotid
artery). He was discharged two weeks after surgery on
prednisone 10 mg/day, MMF 250 mg bid, 4 antihyperten-
sive drugs (enalapril 10 mg/day, nicardipine 60 mg/day,
labetalol 400 mg/day, and clonidine 0.3 mg/day) and
Table 1: Characteristics of our patients with Takayasu arteritis.
Patient 1 Patient 2 Patient 3 Patient 4
Age at diagnosis (years) 12 11 8 15
Gender (M, male; F, female) F M F M
Ethnicity Caucasian Asian Caucasian Caucasian
Clinical presentation -pain left arm -hypertension - hypertension -acute chest pain
-absent radial and brachial pulse, 
weak left carotid pulse
-abdominal pain
Laboratory findings at disease 
onset:
-ESR (mm/hr) 80 125 100 80
-CRP (mg/l) 60 80 134 60
-Hb (g/l) 100 79 92 110
-platelets (G/l) 400 738 487 745
Treatment (initial dose):
-prednisone (mg/kg/day) 2 2 2 1.5
-methotrexate (mg/m2/wk) 10 0 10 10
-MMF (mg bid) 0 250 0 0
Surgical intervention none Bypass brachiocephalic trunk Bypass abdominal aorta None
Follow up (years) 10 3 9 3
Outcome and treatment at last 
visit
-Clinical remission - Clinical remission - Clinical remission - Clinical remission
-prednisone 5 mg/d -prednisone 7.5 mg/d
MMF 750 mg bid
-aspirin 100 mg/d -prednisone 7.5 mg/d
MRA showing right renal artery stenosis with small right kid-ney (arr )Figure 1
MRA showing right renal artery stenosis with small 
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controlled (135/65 mmHg) by three medications; he was
taking prednisone 7.5 mg per day, MMF (750 mg bid),
and low-dose aspirin. His last investigation showed ESR
28 mm/h, Hb 115 g/dL, platelet count 557 G/L, and a nor-
mal renal function. His last MRI angiogram showed nor-
mal visualization of the brachiocephalic trunk and right
internal carotid artery. Neurological examination was
normal, but periodic headaches were still present.
Discussion
Takayasu arteritis has been rarely reported in childhood.
A common clinical mode of disease presentation in our
patients was arterial hypertension (2/4 cases), together
with nonspecific symptoms (headache, fatigue, myalgia,
weight loss). Symptoms due to ischemia, which are fre-
quent in adults, have been seldom reported in children.
However, although true claudication (upon effort) was
present only in one patient, we have observed ischemic
findings (chest, limb, and abdominal pain) in three of our
four patients. The disease is also called 'pulseless disease',
since peripheral pulses are often absent due to vascular
obstruction; however, this feature was present only in one
of our patients. In addition, an abdominal bruit can often
help in the diagnosis, but this was noted in only 1/4 of our
cases.
The largest series of TA in children has been reported by
Hong et al., who described 70 cases [5]; the male to female
ratio was 1:4.4 and the youngest patient was 3 years old.
Arterial hypertension was seen in 65/70 patients (93%).
In another report of 31 children with TA from South
Africa [6], arterial hypertension was the most common
presenting feature, followed by cardiac failure, bruits, and
absent pulses. Jain et al [7] from India reported 24 chil-
dren with TA; again, arterial hypertension was the com-
monest mode of presentation, seen in 83% of patients;
the male to female ratio was 1:5. In a Turkish multicenter
serie, TA represented 1.5% of pediatric vasculitides [8].
Among these patients, 71.4% described constitutional
symptoms. Hypertension was the leading feature, and
renal involvement was present in 86% of cases. Half of the
patients had involvement of both thoracic and abdominal
aorta. Table 2 summarizes clinical findings of main pub-
lished series, as well as our own data.
The diagnosis of TA is based on characteristic findings of
diseased aorta and its major branches seen on angiogra-
phy. This is demonstrated by luminal abnormalities such
as stenosis or aneurysmal dilatation of the aorta, its major
branches, and the pulmonary arteries. With regard to
imaging studies, traditionally the angiographic patterns
have been divided in: type I, affecting the aortic arch; type
II, the thoracic and abdominal aorta; type III, the aorta
both above and below the diaphragm; and type IV, the
aorta and the pulmonary arteries. In our cases type I was
the predominant pattern, whereas in two series type II was
the predominant one [7,9].
Ultrasonography and positron emission tomography are
new, promising techniques to assess large-vessel vascu-
litides. Color-coded Doppler sonography can facilitate an
accurate diagnosis of Takayasu arteritis by the characteris-
tic appearance. Homogeneous circumferential intima-
media thickening of the common carotid arteries is a spe-
cific ultrasonographic finding in patients with Takayasu
arteritis [10-12]. More recently MRI has been used to
establish the diagnosis of TA in children, to monitor dis-
ease activity and to guide treatment. Early in the disease of
TA, smooth muscle thickened vessel walls, which may be
the only manifestation of vascular inflammation, may be
not detected by conventional angiography but MRI can
visualize the thickened vessel wall directly, and in addi-
tion it can show other signs of active inflammation such
as mural edema with T2-weighted imaging and increased
wall vascularity with enhanced imaging [13,14]. For one
patient in our series MRI was used to establish the diagno-
sis of TA and for follow-up. Table 3 summarizes the evo-
lution of vascular involvement in our patients, as studied
by echodoppler, MRI and/or angiography.
With regard to treatment, in our series corticosteroids
have been used in all cases, with the adjunction of meth-
otrexate in three cases and MMF in one. Although the
numbers are small and the retrospective nature of this
report does not allow to draw firm conclusions, our
Table 2: Summary of main clinical features in our series and in published reports of pediatric Takayasu arteritis. 
Gender F/M Hypertension Elevated 
inflammatory 
parameters






Present series 2/2 50% 100% 25% 25% 25% 25%
Ozen et al. [8] 7/7 86% 100% NA NA 57.1% 28.5%
Hong et al. [5] 57/13 93% NA NA NA NA NA
Hahn et al. [6] 13/18 84% 74% 13% 71% 42% 16%
Jain et al. [7] 4/20 83% 42% NA 75% 71% 21%
NA, data not available.Page 3 of 5
(page number not for citation purposes)
Pediatric Rheumatology 2008, 6:17 http://www.ped-rheum.com/content/6/1/17patients have obtained clinical and laboratory remission
with this regimen of early immunosuppression. Our
patients were followed from 2 to 10 years since diagnosis
(mean, 6 years) and medications at the last visit included
only low-dose prednisone in three cases (one of whom
still needed MMF and anti-hypertensives), while the
fourth patient is now only on low-dose aspirin. Bypass
surgery was required in two patients because of severe vas-
cular occlusion, with excellent results as well. One bypass
was carried out between the ascending aorta and the right
carotid artery, the other one between the lower thoracic
aorta and infra-renal aorta; in the latter a reimplantation
of left renal artery and auto transplantation of right renal
artery to common iliac was also performed.
Due to the rarity of the disease, there are no controlled
studies of medical treatment of children with TA. An inter-
esting new possibility is represented by the use of sildena-
fil, that has been recently reported in a 8-year old girl [15].
We have been able to find in the literature only a previous
French case, a 6 year-old girl who was treated with meth-
otrexate [4]. Methotrexate has been used both in adults
and children with good results [16,17]. Mycophenolate
mofetil (MMF) has also recently been introduced in the
treatment of adult patients with TA [18].
TA has been associated with other autoimmune diseases
such as systemic lupus erythematosus, juvenile idiopathic
arthritis, anterior uveitis, sarcoidosis, seronegative spond-
yloarthropathy, Crohn's disease, Wegener's granulomato-
sis, and Sweet syndrome [19-26]. One boy in our series,
who suffered from eczema and thrombocytopenia since
infancy, was diagnosed as having Wiskott-Aldrich syn-
drome (WAS) at the age of 16 years; this was subsequently
confirmed by genetic study. The peculiar association of TA
and WAS has already been mentioned in another previous
report [27].
TA is a disease with severe prognosis, mortality rate being
reported in children from 35 to 40% by five years [28]. It
is therefore important to have a high index of suspicion
and in doubtful cases a low threshold for diagnostic eval-
uation. We underline the possibility of TA in any young
patient with unexplained arterial hypertension.
We conclude that TA is not such a rare disease in a pediat-
ric rheumatology setting, and also that it has to be consid-
ered in cases of unexplained arterial hypertension or
unexplained inflammatory syndromes without signs of
localization. A thorough physical examination can lead to
the correct diagnosis if pulses cannot be felt or if an
abdominal bruit is heard, even if these are not constant
findings. Since the disease can be progressive and life-
threatening, an early recognition is vital in order to start
immunosuppression, which proved to be very successful
in our patients.
Table 3: Vascular involvement during the disease course of our patients as investigated by imaging studies.
At diagnosis On treatment 
(2–5 years after diagnosis)




thrombosis left subclavian artery, left 
carotid thickening
Echodoppler:
stability of previous findings
Echodoppler:
After 6 years 
thickening of left 
carotid artery
Echodoppler:
stability of left carotid 
thickening
Angiography
-reduction left subclavian artery 
diameter without thrombosis, 
hypoplastic left carotid without 
parietal lesions
Patient 2 angioMRI: thrombosis left common 
carotid artery, stenosis left subclavian 
artery, stenosis of the brachiocephalic 
artery, thrombosis descending thoracic 
aorta, right renal artery thrombosis 
and stenosis.
Echodoppler: (after surgery):
patency of left carotid and carotid 
trunk
No flares angioMRI:
normal visualization of the 
brachiocephalic trunk and 
right internal carotid artery
Echodoppler:
left carotid thrombosis, left subclavian 
stenosis, tronc brachiocephalic trunk 
stenosis
Patient 3 Angiography:
left subclavian stenosis, abdominal 
aortic stenosis, superior mesenteric 
artery stenosis, bilateral renal artery 
stenosis
Echodoppler:
stability subclavian lesion, 
improvement aortic wall involvement
Echodoppler:





left subclavian thrombosisPage 4 of 5
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